Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.

On day 30 after autologous peripheral blood stem cell transplantation (PBSCT), 20 patients were randomized to receive either erythropoietin at a dose of 500 U/kg/week s.c. (Epo group) or no treatment (control group). After 3 weeks, hemoglobin (p<0.0001) and serum transferrin receptor (p<0.0001) concentrations were higher in the Epo group. Hb response (+2 g/dL) was achieved in 100% vs 28% (p<0.0001) and Hb correction (> or =13 g/dL) in 70% vs 10% (p=0.0238) of the patients, respectively. This is the first randomized study showing an efficacy of erythropoietin therapy on Hb levels after autologous PBSCT.

[1]  M. Offidani,et al.  Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders , 2004, Bone Marrow Transplantation.

[2]  F. Baron,et al.  Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  F. Baron,et al.  Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. , 2003, Haematologica.

[4]  G. Fillet,et al.  Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. , 1998, Haematologica.

[5]  A. Bosi,et al.  Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial. , 1996, Bone marrow transplantation.

[6]  B. W. Brown,et al.  A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. , 1994, Blood.

[7]  F. Locatelli,et al.  Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. , 1994, Bone marrow transplantation.

[8]  F. Mandelli,et al.  A controlled trial of recombinant human erythropoietin after bone marrow transplantation. , 1994, Blood.

[9]  G. Fillet,et al.  Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. , 1993, Bone marrow transplantation.

[10]  G. Fillet,et al.  Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. , 1991, Blood.